510(k) Report

510(k) · Cleared

Cleared

MR Radiation Oncology Options

K102155510(k) SpecialCleared Aug 31, 201032-day reviewClass II21 CFR 892.1000

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ge Medical Systems, LLC · LNH System, Nuclear Magnetic Resonance Imaging

Cleared on Aug 31, 2010 as substantially equivalent to K081916 (Ge Medical Systems, LLC, 2008) after a 32-day review. Its family tree reaches back 6 generations to 1996. 4 of the 15 devices in its family, counting itself, have a Class I recall. 2 later devices descend from it.

Decided
Aug 31, 2010
Review
32 days
Class
Class II
Product code
LNH
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K962061 (1996). 12 ancestors in all. 2 later devices descend from it, 2 citing it directly. 4 of the 15 devices in this family, counting this one, have a Class I recall.

  1. Root · 6 generations backK962061 Magnetic Resonance Diagnostic SystemGE Medical Systems · 1996 · Recalled
  2. 5 generations backK012200 1.5T Infinity Twinspeed MR SystemGE Medical Systems · 2001 · Recalled (Class I)
  3. 4 generations backK013636 Signa Infinity MR System with Excite TechnologyGE Medical Systems · 2002 · Recalled (Class I)
  4. 3 generations backK041476 GE Signa Excite 1.5T MR System, GE Signa Excite 3.0T MR SystemGe Medical Systems, LLC · 2004 · Recalled (Class I)
  5. 2 generations backK052293 GE 1.5T and 3.0T Signa HDX MR SystemGe Medical Systems, LLC · 2005 · Recalled
  6. 1 generation backK081916 GE Signa MR Oncology PackageGe Medical Systems, LLC · 2008
  7. This deviceK102155 MR Radiation Oncology OptionsGe Medical Systems, LLC · 2010
  8. Descendant · cites it directly · 0 of its ownK123091 Visius Wireless Coils, 1.5T/ Visius Wireless Coils, 3TImris, Inc. · 2012
  9. Descendant · cites it directly · 0 of its ownK121997 Imris Oncology PackageImris, Inc. · 2012

Class I recalls in this family

Most influential descendants

Showing 2 of 2 · See all
  • K123091Visius Wireless Coils, 1.5T/ Visius Wireless Coils, 3TImris, Inc. · 2012 · cites it directly0descendants
  • K121997Imris Oncology PackageImris, Inc. · 2012 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K962061Magnetic Resonance Diagnostic SystemGE Medical Systems19962
−5K0122001.5T Infinity Twinspeed MR SystemGE Medical Systems2001Class I
−4K013636Signa Infinity MR System with Excite TechnologyGE Medical Systems2002Class I
−3K041476GE Signa Excite 1.5T MR System, GE Signa Excite 3.0T MR SystemGe Medical Systems, LLC2004Class I
−2K052293GE 1.5T and 3.0T Signa HDX MR SystemGe Medical Systems, LLC200521
−1K081916GE Signa MR Oncology PackageGe Medical Systems, LLC2008—
0 (this device)K102155MR Radiation Oncology OptionsGe Medical Systems, LLC2010—
+1K123091Visius Wireless Coils, 1.5T/ Visius Wireless Coils, 3TImris, Inc.2012—
+1K121997Imris Oncology PackageImris, Inc.2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
199910
200120
200210
200311

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201220
FIG. 1 — Lineage of K102155, 1996–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

4 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LNH device

  1. #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K081916GE Signa MR Oncology Package
Summary page 1
…2.1000 Magnetic Resonance Diagnostic Device Product Code: LNH Predicate Device(s): GE Signac(i MR Oncology Package, K08 1916 Device Descrip~tion: The MR Radiation Oncology Options includes a radiation therapy insert t…
Ge Medical Systems, LLC2008—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123091Visius Wireless Coils, 1.5T/ Visius Wireless Coils, 3TImris, Inc.20120
K121997Imris Oncology PackageImris, Inc.20120

Has anything in its family been recalled? (4 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K041476GE Signa Excite 1.5T MR System, GE Signa Excite 3.0T MR SystemGe Medical Systems, LLC · 2004 · 3 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K030874GE 3.0T Signa Infinity Twinspeed with Excite MR SystemGeneral Electric Co. · 2003 · 4 generations back · ◆ in the 2003 ancestors bar of FIG. 11 Class I recall
  • K013636Signa Infinity MR System with Excite TechnologyGE Medical Systems · 2002 · 4 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K0122001.5T Infinity Twinspeed MR SystemGE Medical Systems · 2001 · 5 generations back · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 14 years and passes through 2 companies; a new generation was cleared every 2.4 years on median.
  • 7 of the 12 ancestors have a recall of any class; 4 have a Class I recall.
  • Of its descendants, K123091 (Imris, Inc., 2012) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LNH devices

LNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · LNH

26in 2025

2007: 122008: 192009: 172010: 122011: 162012: 222013: 192014: 172015: 192016: 202017: 182018: 292019: 262020: 322021: 272022: 302023: 302024: 262025: 262026 (partial year): 24
2007high 32 (2020) · low 12 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNH

122in 2025

2007: 35 days median2008: 53 days median2009: 70 days median2010: 94 days median2011: 81 days median2012: 89 days median2013: 108 days median2014: 108 days median2015: 140 days median2016: 108 days median2017: 98 days median2018: 128 days median2019: 62 days median2020: 121 days median2021: 87 days median2022: 74 days median2023: 124 days median2024: 104 days median2025: 122 days median2026 (partial year): 126 days median
2007high 140 (2015) · low 35 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LNH

8in 2025

2007: 252008: 122009: 72010: 172011: 112012: 52013: 22014: 132015: 12, 2 Class I2016: 12018: 712019: 52020: 42021: 412022: 132023: 10, 1 Class I2024: 42025: 8, 5 Class I2026 (partial year): 43
2007high 71 (2018) · low 0 (2017)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · LNH

1,263in 2025

2007: 1142008: 1672009: 1942010: 1652011: 1822012: 1702013: 1072014: 1192015: 1132016: 1352017: 1212018: 1582019: 1582020: 982021: 842022: 1382023: 1592024: 2812025: 1,263
2007high 1,263 (2025) · low 84 (2021)2025

MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007123525114
2008195312167
200917707194
2010129417165
2011168111182
201222895170
2013191082107
20141710813119
20151914012 (2)113
2016201081135
201718980121
20182912871158
201926625158
202032121498
202127874184
2022307413138
20233012410 (1)159
2024261044281
2025261228 (5)1,263
20262412643—

What is it indicated for?

The MR Radiation Oncology Options are a patient positioning package intended for use with the GE wide bore MR scanners. The MR Radiation Oncology Options when used with a GE wide bore MR scanner is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio and short scan times. The GE wide bore MR scanners with MR Radiation Oncology Options are indicated for use as a diagnostic imaging device to provide axial…

Read the full statement (252 words)

The MR Radiation Oncology Options are a patient positioning package intended for use with the GE wide bore MR scanners. The MR Radiation Oncology Options when used with a GE wide bore MR scanner is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio and short scan times. The GE wide bore MR scanners with MR Radiation Oncology Options are indicated for use as a diagnostic imaging device to provide axial, sagittal, coronal, and oblique images, spectroscopic images, and/or spectra, dynamic images of the internal structures and organs of the entire body, including but not limited to head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. The images produced by the GE wide bore scanners with MR Radiation Oncology Options reflect the spatial distribution of protons (hydrogen nuclei) exhibiting magnetic resonance. These images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis.

The MR Radiation Oncology Options include a removable patient table insert for GE wide bore MR scanners that allow patients to be imaged on a flat surface. The flat patient surface allows image acquisition in patient positions similar to other modalities that also use a flat patient surface such as X-Ray, CT, PET, and radiation therapy. The GE wide bore MR scanners with the MR Radiation Oncology Options may also be used with MR-compatible patient positioning and immobilization accessories to assist in obtaining consistent patient positions throughout multiple imaging sessions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102155: MR Radiation Oncology Options.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102155

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026